ArticleThoracic cancer2022

Clinical efficacy of dacomitinib in rechallenge setting for patients with epidermal growth factor receptor mutant non-small cell lung cancer: A multicenter retrospective analysis (TOPGAN2020-02).

Hisashi Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.